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Abstract
Background
Several studies have been conducted quantifying the impact of schistosome infections on
health and development in school-aged children. In contrast, relatively little is known about
morbidity levels in preschool-aged children (5 years) who have been neglected in terms of
schistosome research and control. The aim of this study was to compare the utility of avail-
able point-of-care (POC) morbidity diagnostic tools in preschool versus primary school-
aged children (6–10 years) and determine markers which can be used in the field to identify
and quantify Schistosoma haematobium-related morbidity.
Methods/Principal Findings
A comparative cross-sectional study was conducted to evaluate the performance of current-
ly available POCmorbidity diagnostic tools on Zimbabwean children aged 1–5 years
(n=104) and 6–10 years (n=194). Morbidity was determined using the POC diagnostics
questionnaire-based reporting of haematuria and dysuria, clinical examination, urinalysis
by dipsticks, and urine albumin-to-creatinine ratio (UACR). Attributable fractions were used
to quantify the proportion of morbidity attributable to S. haematobium infection. Based on re-
sults of attributable fractions, UACR was identified as the most reliable tool for detecting
schistosome-related morbidity, followed by dipsticks, visual urine inspection, question-
naires, and lastly clinical examination. The results of urine dipstick attributes showed that
proteinuria and microhaematuria accounted for most differences between schistosome
egg-positive and negative children (T=-50.1; p<0.001). These observations were consistent
in preschool vs. primary school-aged children.
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Conclusions/Significance
Preschool-aged children in endemic areas can be effectively screened for schistosome-
related morbidity using the same currently available diagnostic tools applicable to older
children. UACR for detecting albuminuria is recommended as the best choice for rapid as-
sessment of morbidity attributed to S. haematobium infection in children in the field. The use
of dipstick microhaematuria and proteinuria as additional indicators of schistosome-related
morbidity would improve the estimation of disease burden in young children.
Author Summary
Schistosomiasis is a major parasitic disease affecting children in Africa, with impacts on
health, growth and cognitive development. Recently, the World Health Organization has
recommended inclusion of preschool-aged children (5 years) in schistosome control
programmes. However, so far the performance of available morbidity diagnostic tools has
not been thoroughly evaluated in this age group. To address this knowledge gap, we con-
ducted a study in preschool children comparing the utility of currently available point-of-
care tools for diagnosing Schistosoma haematobium-related morbidity, namely: question-
naire-reported haematuria and dysuria, clinical examination, dipstick urinalysis, and
measurement of urine albumin-to-creatinine ratio (UACR). We also investigated the per-
formance of these tools in older children (6–10 years). Our study identified UACR as the
most reliable tool for detecting schistosome-related morbidity in terms of the morbidity
attributable to schistosome infection, followed by dipsticks, visual urine inspection, ques-
tionnaires, and lastly clinical examination The study further showed that the tools current-
ly used in school-aged children for diagnosing schistosome-related morbidity can be
extended to preschool children, allowing easier integration of this age group into treatment
and monitoring programmes.
Introduction
Urogenital schistosomiasis is a major parasitic disease caused by Schistosoma haematobium af-
fecting children in Africa, with negative impacts on child health, growth and cognitive develop-
ment [1]. Chronic infection with the parasite can cause anaemia, malnutrition, and organ
complications such as bladder fibrosis and kidney failure [2]. Schistosome control programmes
focus on preventive chemotherapy with the antihelminthic drug of choice, praziquantel, to re-
duce or prevent the development of severe morbidity due to schistosome infection, and thereby
improving health of the infected individuals and communities [3]. In order to achieve these
goals and evaluate the effects of control programmes, an understanding of the morbidity due
to schistosome infection is essential [4]. This requires the use of reliable rapid diagnostic tools
that can be used in the field [5].
In recent years progress has been made towards improving methods for measuring S. hae-
matobium-related morbidity and various techniques have been evaluated in older children and
adult populations [5]. For example, ultrasonography has been shown to be effective in detect-
ing organ-specific morbidity [6,7]. However, the need for specialized equipment and trained
personnel reduces its utility for large population studies in the field. Urinalysis has been used
as a rapid indirect assessment tool for early urinary tract morbidity due to schistosomiasis [8].
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In addition, standardized questionnaires recommended by the WHO for rapid screening of S.
haematobium infection and morbidity have been extensively used in endemic regions [9].
Most of these studies have focused on older children, typically primary school-aged children
(6–10 years), or older individuals.
The WHO has recently recommended the inclusion of preschool children (aged 5 years and
below) in schistosome control programmes [10], but the performance of the currently available
point-of-care (POC) diagnostic tools for detecting schistosome-related morbidity have not yet
been systematically evaluated in this age group. In addition, the utility of these POC tools has
not been compared in a single study between preschool and primary school-aged (6–10 years)
children, who are the current main targets of schistosome control programmes. Measuring the
burden of schistosome disease in the whole population, including preschool children is impor-
tant for the assessment of the effectiveness of control programmes and thus their prioritization
and sustenance in affected countries (often with limited health budgets). Although extensive
work has been done and a few recent studies published on morbidity due to S.mansoni infec-
tion in preschool children [11], to date there is still a paucity of studies quantifying the burden
of S. haematobium-related morbidity in preschool children and the applicability of current
POC morbidity diagnostics in these young children has not been extensively evaluated. To ad-
dress this knowledge gap, we conducted a study in preschool and primary school children en-
demically exposed to S. haematobium infection assessing the utility of available diagnostic tools
in identifying POC markers of schistosome-related morbidity.
The first aim of the study was to characterise the morbidity in the children detected using
the available POC tools. Since the morbidity markers currently used are general as opposed to
being schistosome specific, they may detect morbidity unrelated to schistosome infection.
Therefore, the second aim of the study was to relate the measures of morbidity to schistosome
infection and determine the fraction of morbidity attributable to schistosome infection. The
overall results would allow us to determine if POC diagnostics available for use in primary
school-aged children can be reliably used in the field to quantify and monitor levels of morbidi-
ty attributable to S. haematobium infection in young children aged 5 years and below.
Materials and Methods
Ethical statement
Ethical and institutional approval for the study was obtained from theMedical Research Council
of Zimbabwe and the University of Zimbabwe, respectively. Permission to conduct the study
was received from the Provincial Medical Director, the District Educational Officer, and Heads
of schools in the study area. Study aims and procedures were explained to participants, and
their parents/guardians in the local language, Shona. Prior to enrolment of study participants,
written informed consent was obtained from parents/guardians and oral assent obtained from
children. The children were recruited into the study on voluntary basis and were free to with-
draw at any time with no further obligation. After sample collection, participants were offered
treatment with the standard dose of 40 mg/kg praziquantel, administered by the local physician.
The praziquantel drug was procured from a local supplier (Pharmaceutical and Chemical Dis-
tributors (Pvt) Ltd, Harare, Zimbabwe), registered and licensed to sell the drug in Zimbabwe.
Study area
The cross-sectional study was conducted in Murewa district, in the north-east of Zimbabwe
(31°90'E; 17°63'S) where S. haematobium is endemic. Prevalence of S.mansoni was low
(<10%) [9] in this current study population as previously reported in other studies conducted
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in the same area [12,13]. There were no soil-transmitted helminths infections detected in this
study population.
Participants
Children aged 1–10 years were recruited from crèches, early child development centres, and
local primary schools between February 28, and March 09, 2012. To be included in this study,
participants had to meet the following criteria: (1) been lifelong residents of the study area,
(2) had no prior history of antihelminthic treatment (assessed by questionnaires administered
to parents/guardians for all children), and (3) provided at least two urine, and two stool sam-
ples for parasitological examinations on consecutive days. The exclusion criteria were: (1) pre-
senting with clinical symptoms of tuberculosis or malaria/fever, (2) recent major illness/
operation, and (3) diagnosed positive for soil-transmitted helminths. None of the children
were excluded based on these criteria.
Parasitology and serology
S. haematobium infection was determined by microscopic enumeration of eggs in urine pro-
cessed using the standard urine filtration method [14]. Children were classified as infected if at
least one parasite egg was detected in any of their urine samples collected on consecutive days.
Infection intensity was defined as the arithmetic mean egg counts/10 mL of at least two urine
samples collected on three consecutive days. Stool samples were processed using the Kato-Katz
method, with duplicate thick smears (41.7 mg) performed per sample [15], and subsequent egg
enumeration by microscopy for the diagnosis of S.mansoni and soil-transmitted helminths.
Children were designated infected with S.mansoni or soil-transmitted helminths if at least one
parasite egg was detected in any of the two stool samples collected on consecutive days. A small
proportion, 6.0% (n = 18) of the children in our study was found positive for S. mansoni. We
compared the morbidity characteristics of these children to those of a random sample drawn
from age and sex matched S. mansoni negative children and no differences were observed,
hence these children were kept in our study for the final analyses. None of the children in this
study were found positive for STHs.
We have recently shown that egg count lacks sensitivity in diagnosing light schistosome in-
fections in children [16]. Thus, in addition to parasitology, IgM antibody responses directed
against soluble egg antigens (SEA) were used to improve the diagnosis of S. haematobium in-
fection. Details of the protocols used to quantify the serum antibody levels are published else-
where [17]. Children were categorized as infected based on serology if their anti-egg IgM
antibody levels were more than two standard deviations above the mean estimated from sera of
negative controls, as outlined in our recently published study [16].
Morbidity measurement
Urinalysis. Urine samples collected on the first day of the survey were examined for visible
haematuria. Uristix reagent strips (Uripath, Plasmatec, UK) were used to test for the presence of
nitrites, leucocytes, blood (microhaematuria), proteins (proteinuria), and physical characteris-
tics (pH, specific gravity). To assess observer bias in dipstick readings, a random sample of 102
of the 298 urine samples was further tested using theMultistix 10SG (Bayer, UK), and the results
read automatically using Siemens' CLINITEK Status+ Analyzer (Bayer, UK). For all the attri-
butes tested, a high proportion of overall agreement (poverall>60.0%) between the two dipstick
tests was noted, showing no evidence of significant observer effect. CLINITEKMicroalbumin
Reagent Strips (Bayer, UK) were used to determine urine albumin-to-creatinine ratio (UACR)
threshold levels on first day urine samples. Following manufacturer’s guidelines, high-abnormal
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UACR (>33.9 mg/mmol) was used to ascertain presence of albuminuria [18], a biological mark-
er of urinary tract infection and an early predictor of progressive kidney disease [8].
Questionnaires. A pre-tested questionnaire on recent/current presence of haematuria and
dysuria, constructed in English and translated to the local language, Shona, was administered
to parents/guardians of preschool-aged children. An alternative version of the questionnaire
was administered to the primary school-aged children.
Clinical examination. All participants underwent a non-intrusive clinical examination,
involving abdominal palpation, conducted by experienced study clinicians to determine cur-
rent health status and schistosome-related anomalies (e.g., epigastric or abdominal pains).
Statistical methods
Sample size calculation. Our pre-study simulations revealed that a sample size of 129 chil-
dren would provide 80.0% power to detect age group related differences in infection prevalence
differences at α = 0.05, allowing for 5.0% non-compliance loss. These sample size calculations
were based on the expected overall S. haematobium infection prevalence of 40.0% (for 1–5 years)
and 60.0% (for 6–10 years), with information obtained from preliminary studies conducted in
the same study area. Our final sample sizes for variables of interest were sufficiently large for sta-
tistical analyses (Fig. 1).
Statistical analyses. Correlations between continuous variables were measured using the
Pearson’s correlation coefficient (r). The phi-coefficient (φ) was used for dichotomous variables.
The chi-square (χ2) test was used to determine associations between different markers of mor-
bidity by sex, age-group or S. haematobium infection status. Multiple logistic regressions were
used to investigate factors influencing the prevalence of schistosome-related morbidity. Each of
the morbidity indicators was included as a response variable, with sex (male vs. female), age-
group (1–5 vs. 6–10 years) and S. haematobium infection status (determined by parasitology or
serology) or infection intensity (log10[egg count+1]-transformed) included as risk factors in the
models. Two-way interaction effects were included in model building, however, none were found
to be significant and hence were subsequently dropped from the final models used for inferences.
Non-metric multidimensional scaling (NMDS) was used to explore the variability in dipstick
attributes between children. For an outline of the NMDS modelling steps (see S1 File Supporting
Information which explains the algorithm steps followed in this study and the test statistics used
to evaluate the NMDS models). Correlation coefficients were used to identify dipstick attributes
contributing most to overall variability in schistosome-related morbidity. The proportion of var-
iability explained by each of the NMDS axes was measured using the coefficient of determina-
tion (R2R2). The multi-response permutation procedure (MRPP) was used to test the null
hypothesis of no significant differences between subgroups. For each pairwise comparison, the
resultant test-statistic (T) was reported along with the corresponding p-value [19].
The risk of morbidity for each age group was estimated using prevalence ratios, where a
prevalence ratio greater than one indicated a positive association between schistosome infec-
tion and presence of related morbidity. The Breslow-Day test with Tarone’s adjustment for
small sample sizes [20], was used to assess whether the probability of detecting morbidity using
the different diagnostic tools in infected children differed between 1–5 years and 6–10 years
old children. The population attributable fraction, and attributable fraction infected were used
to estimate the proportion of morbidity in the whole study population and among infected
children that could be attributed to S. haematobium infection respectively, adjusting for the ef-
fects of sex and age group. Furthermore, these estimates were used to compare the utility of the
different diagnostic tools for detecting schistosome-related morbidity. Approximate 95% confi-
dence intervals were calculated using the method described elsewhere [21]. For meaningful
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interpretations, attributable fractions were only estimated for the morbidity markers with a
prevalence ratio (PR) significantly greater than one.
Sample size calculations were performed using StatXact v.8 (Cystel Software Corp, Cam-
bridge, MA, USA). The NMDS analysis was performed using PCORD 6.08 (MjM Software,
Gleneden Beach, Oregon, USA). Statistical modelling and tests for associations were performed
using SAS 9.3 (SAS Institute Inc., Cary, NC, USA). In all analyses, the level of significance was
set at p<0.05.
Results
Demographics
298 children (1–5 years: n = 104, median = 4 years; 6–10 years: n = 194, median = 8 years) fulfilled
the study criteria (Fig. 1), and these comprised of 142 (47.7%) males, and 156 (52.3%) females.
Fig 1. Flowchart indicating number of children enrolled in the study and excluded from the final analysis.
doi:10.1371/journal.pntd.0003649.g001
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Schistosome infection levels
The overall prevalence of S. haematobium infection determined by parasitological examination
was 35.9% (95% CI: 30.4–41.4%). When looking at infection intensities, 28.9% (95% CI: 23.7–
34.0%) and 7.0% (95% CI: 4.1–10.0%) of these children carried respectively light and heavy in-
fection intensities according to the WHO categorizations [8]. Infection prevalence amongst
primary children aged 6–10 years was 47.9% (95% CI: 40.8–55.0%), and was significantly
higher (χ2 = 35.0; p<0.001) compared to infection prevalence of 13.5% (95% CI: 6.8–20.1%)
observed in 1–5 years old children. However, there was no significant difference (χ2 = 0.5;
p = 0.466) in the prevalence of infection between male and female children. Infection intensity
increased significantly with age (r = 0.4; p<0.001), with the highest levels observed between the
ages of 8–10 years. The prevalence of S. haematobium infection determined by serology was
higher than that determined by egg counts in both age groups, 1–5 years: 52.9% (95% CI:
38.8–67.1%), and 6–10 years: 84.1% (95% CI: 78.3–89.9%).
Urinary dipstick morbidity markers
Dipstick-detected microhaematuria and proteinuria, contributed most to the observed variability
in morbidity among children (taking into account urine’s physical characteristics, pH and specif-
ic gravity), as indicated by the strong correlations (see S1 Table). The variability of morbidity dif-
fered significantly between S. haematobium egg negative and positive children (T = -50.7;
p<0.001) and between the two age groups (T = -19.3; p<0.001), however there were no differ-
ences by sex (T = -1.5; p = 0.089). Furthermore, the observed differences were evident from the
large NMDS ordination output distances between the respective subgroup centres shown in
Fig. 2. Based on the serological diagnosis of infection, significant differences were also observed
by infection status (T = -14.0; p<0.001), age group (T = -6.5; p<0.001), but not by sex (T = -2.5;
p = 0.068). In addition, microhaematuria and proteinuria alone explained about two-thirds of
the overall variability due to differences between infected and uninfected children (detected by ei-
ther parasitology or serology).
Observed morbidity prevalence
The prevalence of dipstick microhaematuria was higher than questionnaire-reported haema-
turia, which in turn was also higher than visible haematuria (Fig. 3). The morbidity prevalence
results illustrated in Fig. 3 revealed that children aged 6–10 years tended to report morbidity
more frequently compared to parents/guardians of 1–5 years old children. In addition, albumin-
uria (detected by UACR) and dipstick proteinuria were observed in both age groups as shown
in Fig. 3. A positive association of albuminuria with microhaematuria (φ = 0.2, p = 0.002), or
proteinuria (φ = 0.4; p<0.001) was observed. In comparison to other diagnostic techniques in-
vestigated in this study, visual urine inspection, and clinical examination detected the least num-
ber of morbidity cases (Fig. 3).
Schistosome infection versus morbidity prevalence
Results of multiple logistic regression analyses revealed a significant positive association (in
order of strength of the association) of visible haematuria, albuminuria, microhaematuria, and
proteinuria with S. haematobium infection detected by parasitology as shown in Table 1. In ad-
dition, S. haematobium infection prevalence determined by serology was also found to be sig-
nificantly associated with albuminuria and proteinuria, adjusting for the effects of sex and age
group (Table 1). Significant increases in prevalence of albuminuria (Odds ratio (OR) = 5.5;
p<0.001), visible haematuria (OR = 4.7; p<0.001), microhaematuria (OR = 3.4; p = 0.005),
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and proteinuria (OR = 3.3; p<0.001) with infection intensity were observed. However, no sig-
nificant associations between infection intensity and questionnaire-reported haematuria and
dysuria, or clinical examination detected morbidity were found.
Fig 2. Non-metric multidimensional scaling (NMDS) ordination in 2-dimensional configurations by
sex, age-group and S. haematobium infection status determined using parasitological (A) and
serological diagnostic techniques (B). Subgroup centres are represented by the bigger closed (●), or open
() points, and the distance between these centres is proportional to the level of dissimilarities
between subgroups.
doi:10.1371/journal.pntd.0003649.g002
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Morbidity attributable to S. haematobium infection
Since the morbidity markers are not specific to schistosomes but are general markers of differ-
ent physiological and biochemical processes, we went further to determine how much of the
morbidity was attributable to schistosome infection. There was no significant difference in the
estimated probability of detecting morbidity between 1–5 years and 6–10 years old children
using each of the diagnostic tools (Table 2). In addition, from Table 2, it was observed that
morbidity detected by dipsticks (microhaematuria and proteinuria), UACR (albuminuria), and
urine inspection (visible haematuria) had prevalence ratios significantly greater than one. Clin-
ical examination detected morbidity had the lowest prevalence ratio (Table 2). Furthermore,
the results indicated that albuminuria was the dominant marker of schistosome attributable
morbidity at population level, as well as amongst infected children (Fig. 4). Proteinuria and vis-
ible haematuria were also found to be highly attributable to schistosome infection among
Fig 3. Observed prevalences of morbidity by age group, assessed using different diagnostic tools. Error bars indicate the 95% confidence intervals.
doi:10.1371/journal.pntd.0003649.g003
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Table 1. Multiple logistic regression odds ratios (OR) to investigate factors associated with the prevalence of morbidity assessed using different
diagnostic tools.
Infection detected by
parasitology
Infection detected by
serology
Type of morbidity Diagnostic tool used Variable OR (95% CI) p OR (95% CI) p
Microhaematuria Dipstick Sex (M vs. F) 1.8 (0.9–3.4) 0.089 2.7 (1.1–6.7) 0.031
Age group (1–5 vs. 6–10 years) 1.2 (0.6–2.4) 0.563 1.4 (0.5–3.9) 0.472
Infection status (negative vs. positive) 3.4 (1.5–7.9) 0.005 0.9 (0.3–2.7) 0.902
Proteinuria Dipstick Sex (M vs. F) 1.2 (0.6–2.1) 0.594 1.2 (0.6–2.3) 0.564
Age group (1–5 vs. 6–10 years) 2.5 (1.2–5.5) 0.019 2.0 (0.8–4.9) 0.145
Infection status (negative vs. positive) 3.3 (2.2–5.0) <0.0001 4.5 (1.5–13.6) 0.007
Albuminuria UACR Sex (M vs. F) 0.8 (0.4–1.5) 0.528 0.8 (0.4–1.5) 0.481
Age group (1–5 vs. 6–10 years) 3.1 (1.5–6.7) 0.004 3.4 (1.3–8.5) 0.011
Infection status (negative vs. positive) 5.5 (3.4–8.9) <0.0001 33.9 (4.5–254.0) 0.001
Haematuriaa Visual inspection Sex (M vs. F) 1.1 (0.3–3.6) 0.876 1.4 (0.3–5.9) 0.690
Age group (1–5 vs. 6–10 years) 0.5 (0.1–1.9) 0.299 1.0 (0.2–5.3) 0.991
Infection status (negative vs. positive) 7.8 (1.8–34.4) 0.007 - -
Haematuria Questionnaire Sex (M vs. F) 1.0 (0.5–2.4) 0.931 1.6 (0.6–4.2) 0.349
Age group (1–5 vs. 6–10 years) 3.9 (1.4–10.8) 0.009 5.5 (1.1–27.6) 0.037
Infection status (negative vs. positive) 1.4 (0.6–3.3) 0.443 2.1 (0.4–11.2) 0.385
Dysuria Questionnaire Sex (M vs. F) 0.6 (0.3–1.6) 0.325 0.6 (0.2–1.4) 0.223
Age group (1–5 vs. 6–10 years) 4.1 (1.3–12.6) 0.013 2.5 (0.7–9.1) 0.168
Infection status (negative vs. positive) 1.0 (0.4–2.4) 0.926 1.6 (0.4–6.9) 0.531
Abdominal/ Clinical exam Sex (M vs. F) 0.9 (0.3–2.5) 0.826 1.2 (0.4–3.5) 0.788
epigastricb Age group (1–5 vs. 6–10 years) - - - -
Infection status (negative vs. positive) 0.9 (0.3–2.6) 0.882 1.2 (0.3–4.4) 0.821
Signiﬁcant effects (p<0.05) are shown in bold.
aOR not adjusted for serological infection status;
bOR not adjusted for age group effect.
doi:10.1371/journal.pntd.0003649.t001
Table 2. Estimates of prevalence ratios (PR) weighted by age group for each of the morbidity markers assessed using different diagnostic tools
and test for homogeneity of the probability of detectingmorbidity in infected children.
Infection detected by parasitology Infection detected by serology
Type of morbidity Diagnostic tool used PR (95% CI) χ2-statistic p PR (95% CI) χ2-statistic p
Microhaematuria Dipstick 3.3 (1.4–7.9) 1.4 0.231 0.9 (0.5–2.6) 0.4 0.509
Proteinuria Dipstick 1.5 (1.2–1.8) 0.2 0.666 1.3 (1.1–1.5) 2.5 0.114
Albuminuria UACR 2.4 (1.9–3.1) 0.01 0.927 1.7 (1.4–1.9) 0.3 0.571
Haematuria Visual inspection 1.1 (1.0–1.2) 0.002 0.989 1.5 (1.3–1.7) a a
Haematuria Questionnaire 1.1 (0.8–1.5) 5.1 0.024 1.1 (0.9–1.5) 1.5 0.225
Dysuria Questionnaire 1.0 (0.8–1.3) 3.1 0.078 1.1 (0.8–1.6) 5.5 0.017
Abdominal/epigastric Clinical exam 1.0 (0.3–2.9) 3.0 0.081 1.0 (0.9–1.1) a a
Comparisons between preschool-aged (1–5 years) versus primary school-aged (6–10 years) children. Prevalence ratios signiﬁcantly higher than 1 are
shown in bold.
aTest statistic could not be computed.
doi:10.1371/journal.pntd.0003649.t002
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infected children. Although a high crude prevalence of microhaematuria was observed initially,
the analyses revealed that a relatively small proportion of microhaematuria was attributed to S.
haematobium infection (Fig. 4). The attributable fractions among infected children estimated
by age group strata (see S1 Fig) showed a similar trend to the overall estimated attributable
fractions noted above.
Discussion
Until recently, most schistosome control programmes in Africa aimed at reducing develop-
ment of severe morbidity and improving child health have focused on regular school-based de-
worming strategies, targeting children above five years old [22–24]. By focusing treatment
upon the school-aged population, children of preschool-age have been previously neglected in
terms of research and control [25]. Consequently, less is known about the levels of schisto-
some-related morbidity in this age-group. Furthermore, research studies evaluating the perfor-
mance of the current POC markers of schistosome-related morbidity in children aged five
years and below are still limited [11]. Estimation of disease burden due to schistosome infec-
tions in children has been further complicated by the fact that signs and symptoms commonly
associated with schistosomiasis can also be due to other causes [26]. In the absence of a gold
standard POC morbidity diagnostic technique, several methods have been used in studies from
different endemic settings in older children (6 years) and adult populations [5]. Our study fo-
cused on the tools used in the field; the WHO approved questionnaire-based reporting of hae-
maturia and dysuria, clinical examination by qualified clinicians, routinely used dipstick tests
measuring several urine attributes, and UACR (for detecting albuminuria) which has previous-
ly been evaluated for schistosome morbidity detection [8]. We investigated how these tools per-
formed in preschool-aged children (1–5 years) compared to primary school-aged children (6–
10 years), who are the current targets of schistosome control programmes.
Our study revealed that children of the two age groups carried quantifiable levels of morbidi-
ty as determined by these different diagnostic tools. This finding is in accordance with a recent
Fig 4. Estimated proportion of morbidity attributable to S. haematobium infection. (A) Population attributable fraction, (B) Attributable fraction infected.
doi:10.1371/journal.pntd.0003649.g004
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epidemiological study by Sacko and colleagues [27] who reported significant prevalence of uri-
nary pathology in endemically exposed children. Of the several urine attributes tested using dip-
sticks, microhaematuria and proteinuria were significantly associated with S. haematobium
infection, as it has been previously reported in several other studies [28–30]. A high proportion
of children aged 5 years and below presented with microhaematuria in this study. More interest-
ingly, the current study demonstrated that the performance of each of the different POC diag-
nostic tools for detecting morbidity did not differ between preschool and primary school-aged
children infected with S. haematobium. These findings are important for planning of future in-
terventions as they provide evidence that children5 years can be effectively screened for prazi-
quantel treatment using the available POC diagnostic tools applicable to older children and
adult populations in the field [27,31].
Since the physical and biological features determined by these diagnostics can arise due to
several conditions [32,33], we determined how much of the proportion of morbidity was attrib-
uted to S. haematobium infection. Based on the results of prevalence ratios and attributable
fractions, UACR was identified as the most reliable tool for detecting schistosome-related mor-
bidity, followed by dipsticks, visual urine inspection, questionnaires and lastly clinical exami-
nation. In addition, prevalence of albuminuria determined using UACR was positively
associated with presence of microhaematuria and proteinuria detected by dipsticks. This find-
ing suggests that these indicators used in combination can be a better predictor of the presence
of urinary tract morbidity due to S. haematobium infection in children than using one test pa-
rameter alone, and thereby facilitating effective and timely interventions. The utility of albu-
minuria as a valuable indicator of schistosome-related morbidity in our study corroborates
earlier findings in school-aged children by Sousa-Figueiredo and colleagues [34].
Although the proportion of children with visible haematuria was low in this study, it was
noted that S. haematobium egg-positive children were eight times more likely to present with
visible haematuria compared to egg-negative children. In addition, all children with visible hae-
maturia were positive for S. haematobium infection detected using the serological diagnostic
test. The majority of children in this study carried light infections, and this could explain the
observed low prevalence of visible haematuria [35].
Since S. haematobium infection in endemic areas can easily be inferred from presence of
blood in urine, questionnaire responses about recent/current presence of haematuria and dys-
uria can be used to assess schistosome-related morbidity. Our study showed some level of bias
in the reporting of haematuria and dysuria between preschool-aged children, where the an-
swers were provided by the parents/guardians and primary school-aged children, who re-
sponded to the questions themselves. One theoretical explanation for these observations could
be that children easily mistook concentrated urine as blood in urine, but less likely so by adults
and hence resulting in the overestimation of the prevalence of reported morbidity amongst the
6–10 years old children. These results therefore need to be interpreted with caution.
Physical clinical markers of morbidity were least attributable to schistosome infection, as
previously mentioned. Our findings are consistent with a recent study by Agnew-Blais and col-
leagues [36], who also reported inadequacy of the physical examination method for assessing
schistosome-related pathology in school-aged populations.
Nevertheless, there are some limitations when interpreting the results of our study. Firstly,
given that approximately 30% of our study participants were not characterized for S. haemato-
bium infection using the more sensitive serological diagnostic technique, caution must be ap-
plied when extrapolating the study findings. Secondly, in our stratified analysis the sample size
was too limited to give precise estimates of schistosome-related morbidity prevalence measured
using different markers; these results should be interpreted with caution.
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Conclusions
Our results confirm that schistosome infection in preschool children does result in significant
morbidity. These findings are in agreement with recent studies on S.mansoni in Uganda [11]
and S. haematobium in Malawi [37], reiterating the need for anthelminthic treatment in pre-
school children. This study has gone further to identify morbidity diagnostics with large frac-
tions attributable to schistosome infection, highlighting detection of albuminuria as the best
choice for rapid assessment of morbidity attributed to S. haematobium infection in children in
the field. Finally the study showed that in S. haematobium endemic areas, preschool-aged chil-
dren can be effectively screened for schistosome-related morbidity using the same diagnostic
tools applicable to primary school-aged children and adult populations These findings are of
clinical and public health importance, as these tools can be used to identify affected individuals
or subgroups, thereby facilitating focused and timely delivery of treatment, as well as evaluate
the effectiveness of interventions for improved control.
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